HBK Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,975
| Closed | -$4M | – | 22 |
|
|
2022
Q3 | $4M | Buy |
+19,975
| New | +$4M | 0.03% | 143 |
|
|
2018
Q4 | – | Sell |
-13,131
| Closed | -$1.15M | – | 1042 |
|
|
2018
Q3 | $1.15M | Sell |
13,131
-369
| -3% | -$32.3K | 0.01% | 571 |
|
|
2018
Q2 | $1.33M | Buy |
+13,500
| New | +$1.33M | 0.01% | 515 |
|
|
2016
Q2 | – | Sell |
-49,293
| Closed | -$3.09M | – | 879 |
|
|
2016
Q1 | $3.09M | Buy |
49,293
+38,692
| +365% | +$2.43M | 0.03% | 294 |
|
|
2015
Q4 | $998K | Sell |
10,601
-8,599
| -45% | -$810K | 0.01% | 502 |
|
|
2015
Q3 | $1.54M | Buy |
19,200
+442
| +2% | +$35.5K | 0.02% | 402 |
|
|
2015
Q2 | $2.25M | Sell |
18,758
-34,503
| -65% | -$4.14M | 0.02% | 321 |
|
|
2015
Q1 | $5.56M | Buy |
53,261
+702
| +1% | +$73.3K | 0.05% | 160 |
|
|
2014
Q4 | $5.1M | Buy |
+52,559
| New | +$5.1M | 0.06% | 144 |
|
|
2014
Q3 | – | Sell |
-37,099
| Closed | -$2.34M | – | 876 |
|
|
2014
Q2 | $2.34M | Sell |
37,099
-27,801
| -43% | -$1.76M | 0.05% | 263 |
|
|
2014
Q1 | $4.36M | Buy |
64,900
+53,700
| +479% | +$3.61M | 0.08% | 154 |
|
|
2013
Q4 | $720K | Buy |
11,200
+6,650
| +146% | +$428K | 0.01% | 522 |
|
|
2013
Q3 | $291K | Sell |
4,550
-10,750
| -70% | -$688K | ﹤0.01% | 713 |
|
|
2013
Q2 | $474K | Buy |
+15,300
| New | +$474K | 0.01% | 553 |
|